Stryker Corporation (0R2S.L)
| Previous close | 341.82 |
| Open | 342.92 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 339.90 - 344.93 |
| 52-week range | 250.79 - 359.79 |
| Volume | |
| Avg. volume | 6,578 |
| Market cap | 126.581B |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | 0.65 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Stryker joins Atrium Health affiliate IRCAD North America to advance surgical training and education
Stryker is bringing its innovative products, platforms and robotic technologies to IRCAD North America (IRCAD NA), a subsidiary of Atrium Health, as part of a multi-year agreement supporting the creation of a cutting-edge experiential education center in Charlotte, North Carolina. IRCAD NA is set to become the cornerstone of the first research building at "The Pearl," a new innovation district currently under construction in the heart of Charlotte. It will attract thousands of medical profession
- PR Newswire
Stryker releases LIFEPAK 35 monitor/defibrillator
Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of LIFEPAK 35 monitor/defibrillator, the latest product in the monitor/defibrillator space, offering advanced technology and built on an intuitive1, modern platform to help advance patient care.
- Business Wire
Stryker Announces Definitive Agreement to Acquire Artelon, Inc., Offering a Range of Soft Tissue Fixation Solutions for Orthopaedic Surgeons
KALAMAZOO, Mich., June 03, 2024--Stryker announced the signing of a definitive agreement to acquire all of the issued and outstanding shares of Artelon.
